ReNetX Bio的封面图片
ReNetX Bio

ReNetX Bio

生物技术

New Haven，CT 353 位关注者

关注

关于我们

Our mission is to provide first-in-class therapeutics to treat injury/damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), glaucoma, and traumatic brain injury. Our treatment, AXER-204, hopes to rebuild connections between healthy and damaged neurons through the blocking of receptors that naturally inhibit axonal growth. We are currently approaching Phase 2 of testing.

网站
http://www.renetx.com
所属行业
生物技术
规模
2-10 人
总部
New Haven，CT
类型
私人持股
领域
Biotechnology

地点

  • 主要

    157 Church Street

    19th Floor

    US，CT，New Haven，06510

    获取路线

相似主页

查看职位

融资

ReNetX Bio 共 3 轮

上一轮

未知

US$2,800,000.00

在 Crunchbase 上查看更多信息